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Abstract Copper is an essential dietary trace metal, however
the mechanisms involved in intestinal copper uptake are unclear.
Two putative copper transporters are expressed in Caco-2 cells,
the divalent metal transporter (DMT1) and copper transporter
(Ctr1). Our data demonstrate that copper could compete with
iron for uptake via DMT1 and that DMT1 protein and mRNA
expression were decreased following exposure (24 h) to high
copper. Expression of Ctr1, which acts as a copper transporter
in transfected cell lines, was una¡ected by copper treatment.
Interestingly, exposure to copper increased iron e¥ux from
Caco-2 cells and up regulated IREG1 (iron-regulated mRNA)
expression. - 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
Copper is an essential trace metal required for a number of
key physiological and biochemical functions in the body. Cop-
per can exist in either the reduced (Cuþ) or oxidised (Cu2þ)
state and can therefore act as an important co-factor in a
number of fundamental redox reactions. However, due to
this powerful redox activity, excess copper can lead to the
production of the highly damaging hydroxyl radical. None-
theless, copper-requiring proteins are widespread and are in-
volved in a number of biological processes including oxidative
phosphorylation (cytochrome c oxidase), cellular antioxidant
status (superoxide dismutase) and oxidation of iron (cerulo-
plasmin). To maintain these essential processes, dietary cop-
per intake must match endogenous copper losses (mainly via
the bile) of 0.6^1.6 mg copper per day. Accordingly, copper is
readily absorbed from the diet (up to 60% of the daily intake),
mainly in the duodenum and early jejunum [1,2], and rapidly
dispersed to the copper-requiring proteins. The precise mech-
anisms controlling copper uptake are unclear, but evidence
suggests that they can be regulated at the intestinal level in
line with the body’s copper requirements, i.e. decreased ab-
sorption is observed following exposure to high copper levels,
whilst absorption is increased by low copper intake [3].
Two high a⁄nity copper transporters (Ctr1 and Ctr3) have
been identi¢ed in the yeast S. cerevisiae [4,5], which have a Km
in the low micromolar range. Studies using complementation
strategies with yeast Ctr mutants have identi¢ed candidate
mammalian homologues of these proteins [6,7]. Human Ctr1
can functionally complement yeast lacking Ctr1 and Ctr3 [6],
suggesting that the protein may function as a copper trans-
porter in mammalian cell systems. Recently, mammalian Ctr1
has been shown to be ubiquitously expressed with the highest
levels being found in the liver and kidney [6,7]. In support of a
major role for Ctr1 in mammalian copper homeostasis, stud-
ies using Ctr1 knockout mice have shown that the homozy-
gotes died in utero with severe developmental defects at the
time of death, while heterozygotes have severely restricted
tissue copper levels [8,9]. In addition, studies with Hek293
cells transfected with human Ctr1 have shown that the protein
is expressed at the plasma membrane and acts as a copper
transporter [10].
The divalent metal transporter (DMT1), a member of the
Nramp (natural resistance-associated macrophage proteins)
superfamily of proteins (reviewed in [11]), may represent an
alternative copper uptake pathway since expression of DMT1
in Xenopus oocytes results in transport of several divalent
metals including Fe2þ, Cd2þ, Cu2þ and Mn2þ [12]. The pur-
pose of our current work was to study the expression of the
putative copper transporters Ctr1 and DMT1 in the Caco-2
TC7 cell model of human intestinal epithelial cells and to
investigate the e¡ects of copper-supplemented medium on
metal transporter mRNA.
2. Materials and methods
2.1. Materials
Radiochemicals and materials for Western blotting were supplied
by Amersham Pharmacia Biotech UK Ltd, Buckinghamshire, UK.
Cell culture medium, heat-inactivated foetal bovine serum and plas-
ticware were purchased from Life Technologies (Paisley, UK) unless
stated. All other chemicals were of the highest grade available and
bought from Sigma-Aldrich (Poole, Dorset, UK) or Merck (Poole,
Dorset, UK).
2.2. Cell culture
Caco-2 TC7 cells were maintained in 25 cm2 plastic £asks and
cultured in a 90% air/10% CO2 atmosphere in Dulbecco’s modi¢ed
Eagle’s minimal essential medium, supplemented with 20% heat-inac-
tivated foetal bovine serum. All experiments were carried out on cells
between passage numbers 32 and 42. For experiments, cells were
seeded at a density of 1U104 cells/cm2 onto Transwell inserts (Costar
UK, Buckinghamshire, UK) to measure iron transport, or 75 cm2
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tissue culture £asks for isolation of plasma membrane protein and
total RNA, and used 21 days later. Cells were incubated in the pres-
ence or absence of 100 WM Cu2þ for the ¢nal 24 h of the culture
period to determine the e¡ects of increased copper on metal trans-
porter expression.
2.3. Transepithelial iron £ux across Caco-2 TC7 cell monolayers
The measurement of iron uptake by Caco-2 TC7 cells has been
described previously [13]. The integrity of cell monolayers was deter-
mined for each well before all uptake experiments by measuring trans-
epithelial resistance (TER, measured as 6.cm2), using a Millicell elec-
trical resistance system (Millipore UK Ltd, Watford, UK). Cell
monolayers with a TER of less than 200 6.cm2 were excluded from
experiments. Transepithelial pH gradients were produced using
HEPES (N-2-hydroxyethylpiperazine-NP-2-ethanesulphonic acid)-bu¡-
ered salt solution (HBSS, pH 7.5; 140 mM NaCl, 5 mM KCl, 1 mM
Na2HPO4, 1 mM CaCl2, 0.5 mM MgCl2, 5 mM glucose, 10 mM
HEPES, 0.2% bovine serum albumin) in the basolateral chamber,
with either HBSS or MBSS (pH 5.5 ^ substituting 2-(N-morpholino)-
ethanesulphonic acid for HEPES) added to the apical chamber. Up-
take was initiated by the addition of 1 or 10 WM 55Fe2þ complexed
with 1 mM ascorbic acid (prepared freshly prior to the start of each
experiment) to the apical chamber and terminated after 60 min. Cells
were washed three times in ice cold transport bu¡er containing a
10-fold excess of iron, solubilised overnight in 200 mM NaOH, and
¢nally subjected to scintillation counting to determine cell uptake.
Aliquots of the basolateral bu¡er were taken to measure transport
across the Caco-2 TC7 epithelium. Parallel experiments in which
[14C]mannitol was substituted for 55Fe were performed to distinguish
the passive transport component.
2.4. Western blot analysis
Following removal of culture medium, cell monolayers were washed
twice in phosphate bu¡er and harvested using a cell scraper. Total
plasma membranes (apical and basolateral pooled) were prepared as
described previously [14] and used for Western blotting.
Cell membranes (20 Wg) were solubilised in sample bu¡er and sub-
jected to 10% SDS^PAGE. The proteins were transferred onto nitro-
cellulose (Hybond ECL ^ Amersham Pharmacia Biotech, Bucking-
hamshire, UK) and blocked overnight in phosphate bu¡er con-
taining 0.05% Tween 20 and 1% fat free milk. The nitrocellulose
was incubated for 2 h at room temperature with either a polyclonal
antibody (1:250 dilution) raised in rabbit against a synthetic peptide
corresponding to amino acids 310^330 of the human DMT1 sequence,
common to both isoforms, or commercially available antibodies to
iron-regulated mRNA (IREG1) (1:500 dilution, Alpha Diagnostics
International, TX, USA) or villin (1:250 dilution, Santa Cruz Bio-
technology Inc, CA, USA). Following removal of the primary anti-
body, a secondary anti-IgG antibody (horseradish peroxidase-la-
belled) was used, and cross reactivity visualised using ECL Plus and
Hyper¢lm ECL (Amersham Pharmacia Biotech) according to the
manufacturer’s instructions. Band densities were semi-quanti¢ed by
densitometric analysis using Scion Image software (Scion Corpora-
tion, MD, USA).
2.5. Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated from Caco-2 TC7 cells using Trizol re-
agent (Life Technologies, Paisley, UK) and stored at 370‡C in 75%
ethanol until required. RT-PCR was performed in a single step reac-
tion, using Ready-to-go RT-PCR Beads (Amersham Pharmacia
Biotech) on total RNA samples (1 Wg per tube) using the following
primer sequences: L-actin 5P-CCAAGGCCAACCGCGAGAAGAT-
GAC-3P (forward), 5P-AGGGTACATGGTGGTGCCGCCAGAC-3P
(reverse); DMT1 (+IRE) 5P-AGTGGTTTATGTCCGGGACC-3P
(forward), 5P-TTTAACGTAGCCACGGGTGG-3P (reverse); DMT1
(non-IRE) 5P-TCTAGATGACTGACAGCC-3P (forward), 5P-CCAA-
GACACAAGCCCATA-3P (reverse); IREG1 5P-ATTGCTGCTAGA-
ATCGGTCT-3P (forward), 5P-AGACTGAAATCAATACGAGC-3P
(reverse); Ctr1 5P-TAAGATTCGGAGAGAGAGGTGC-3P (for-
ward), 5P-AGGCTCTCTCGGGCTATCTT-3P (reverse).
The cDNA transcript was produced by incubation at 42‡C for 30
min. PCR (28 cycles) was in a Hybaid Omn-E thermal cycler (Hybaid
Ltd, Middlesex, UK). PCR products were stained with ethidium bro-
mide on a 2% agarose gel and visualised using Fluor-S MultiImager
(Bio-Rad Laboratories Ltd, Hertfordshire, UK), and bands analysed
using Scion Image analysis software. Transporter mRNA was normal-
ised to L-actin expression.
2.6. Data analysis
Data are presented as the meanTS.E.M. Statistical analysis was
carried out using SPSS statistics package, and utilised one-way anal-
ysis of variance (ANOVA) followed by Sche¡e’s post hoc test, or
Student’s unpaired t-test where appropriate. Di¡erences were consid-
ered signi¢cant at P6 0.05.
3. Results and discussion
As copper is a redox active metal and can cause cytotoxicity
and membrane damage, the integrity of all cell monolayers
was determined immediately prior to commencing transport
experiments by measuring TER. In our studies there was no
signi¢cant di¡erence between the TER of control cells
(256T 41 6.cm2) or copper-treated cells (231T 26 6.cm2).
All wells with a TER of less than 200 6.cm2 were discarded
from the experimental protocol. There was no di¡erence in
paracellular permeability, estimated by [14C]mannitol transfer
from the apical medium to the basolateral chamber, between
control and copper-treated cells (data not shown) indicating
that the monolayer remained intact throughout our studies.
This is in contrast with previous studies showing that high
copper can decrease Caco-2 cell monolayer integrity [15].
These di¡erences could well re£ect our use of a more di¡er-
entiated (in terms of a number of small intestinal markers)
Caco-2 cell subclone [16].
DMT1 expressed in Xenopus oocytes is capable of trans-
porting Fe2þ, Cd2þ, Cu2þ and Mn2þ with equal a⁄nity via
an electrogenic, voltage- and proton-dependent mechanism
[12]. However, more recent work has shown that DMT1 is
predominantly an iron transporter with lower a⁄nity for oth-
er metals [13,17^19]. In our current study, we have demon-
strated that addition of a 100-fold excess of copper could
reduce iron uptake by 50% (P6 0.05), suggesting that copper
has signi¢cant a⁄nity for this transport system (Fig. 1). The
interaction between the biology of copper and iron is well
recognised, particularly in the transport of iron across the
intestinal barrier. A recent study in which Caco-2 cells were
supplemented with copper (1 WM) for the ¢nal 7^8 days prior
to experimentation demonstrated enhanced apical iron uptake
and DMT1 expression [20]. Interestingly, over the 24 h time
Fig. 1. Competition between copper and iron for uptake at the api-
cal membrane of Caco-2 TC7 cells. Uptake of 1 WM 55Fe2þ was sig-
ni¢cantly inhibited in the presence of 100 WM unlabelled iron
(P6 0.001) or unlabelled copper (P6 0.05) compared with control
(ANOVA and Sche¡e’s post hoc test). Data are meansTS.E.M. of
four observations. * indicates that all experimental groups are sig-
ni¢cantly di¡erent from each other (P6 0.05).
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period we found no signi¢cant e¡ect of 1 WM copper on any
of the variables measured in our study (data not shown).
To determine the e¡ect of copper loading on the function
and expression of the apical membrane resident transporter,
DMT1, Caco-2 TC7 cells were incubated for the ¢nal 24 h of
the culture period in the presence of 100 WM CuCl2. Follow-
ing this manoeuvre, pH-dependent iron uptake was signi¢-
cantly decreased (P6 0.01) compared with control cells (Fig.
2a). Taken together, the uptake data (Figs. 1 and 2a) are
consistent with the hypothesis that DMT1 is not only an
iron transporter but may also act as a copper transport path-
way [12]. Ongoing studies in our laboratory are investigating
copper transport kinetics via DMT1. The e¡ects of copper
loading on DMT1 protein and mRNA expression were also
determined. There are two functional splice variants of
DMT1, one contains a single iron responsive element (IRE)
in the 3P untranslated region (UTR), which can bind iron
regulatory proteins (IRPs) in vitro [21,22], whereas the second
isoform lacks this 3P IRE. In agreement with our uptake data,
DMT1 protein expression (our antibody recognises both
DMT1 isoforms) was decreased following 24 h copper treat-
ment (Fig. 2b). Interestingly, exposure to copper signi¢cantly
Fig. 2. E¡ect of copper on DMT1 function and expression. Caco-2 TC7 cells were incubated in the presence of 100 WM copper for the ¢nal
24 h of the culture period. pH-dependent Fe2þ uptake across the apical membrane (a) and DMT1 protein levels (b) (detected on Western blots
as a 66 kDa band) in plasma membranes of Caco-2 TC7 cells were signi¢cantly decreased by high copper (*P6 0.01, Student’s unpaired
t-test). DMT1 (+IRE) mRNA levels were signi¢cantly decreased by exposure to high copper for 24 h (**P6 0.05, Student’s unpaired t-test)
(c), whereas DMT1 (non-IRE) mRNA levels were una¡ected by copper treatment (d). Data are meanTS.E.M. of four to six separate experi-
ments. Two representative bands from control and copper-treated cells are shown above the data bars for DMT1 and for villin (b) and L-actin
(c and d) in the same cell samples to indicate equal loading of protein and RT-PCR products onto gels. Copper treatment did not a¡ect villin
or L-actin densities compared with control cells.
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reduced DMT1 (+IRE) mRNA (Fig. 2c) but had no e¡ect on
DMT1 (non-IRE) mRNA (Fig. 2d). Intestinal copper uptake
is known to be down regulated following exposure to high
dietary copper levels [3]. The copper-mediated decrease in
DMT1 expression gives further credence to a role for the
transporter in copper absorption. Previous work in our labo-
ratory has shown that DMT1 mRNA expression is regulated
by other divalent metals including iron [23,24] and zinc [19].
In agreement with the current copper data, exposure to iron
decreases DMT1 (+IRE) mRNA but does not change in the
non-IRE isoform [24]. Taken together, these data suggest that
the molecular information required for the regulation of
DMT1 by copper and iron resides in the 3P UTR since both
DMT1 isoforms share the same 5P promoter [25]. Support for
this hypothesis is provided by recent data in human hepatoma
cells demonstrating that copper decreases IRP1/IRE binding,
possibly by replacing the labile fourth position iron in the
iron^sulphur cluster of IRP1, and down regulates transferrin
receptor mRNA [26].
Ctr1 represents an alternative copper uptake pathway in
Caco-2 TC7 cells. Ctr1 mRNA was expressed in this cell
Fig. 3. E¡ects of copper on Ctr1 mRNA expression. mRNA expres-
sion of the putative copper transporter Ctr1 in Caco-2 TC7 cells
was unaltered following exposure to high copper for the ¢nal 24 h
of the culture period. Data are meanTS.E.M. of six observations in
each group. L-Actin bands show equal loading of RT-PCR products
from control and copper-treated cells. Band density was not di¡er-
ent in the two groups of cells (data not shown).
C
Fig. 4. E¡ects of copper on iron transport across Caco-2 TC7 cell
monolayers and IREG1 expression. Iron transport, expressed as a
percentage of apical uptake, was signi¢cantly higher following expo-
sure to copper (100 WM) compared with control cells (*P6 0.02
Student’s unpaired t-test) (a). Data are meansTS.E.M. of six obser-
vations in each group. Protein (b) and mRNA (c) expression of the
basolateral iron transporter, IREG1, were both signi¢cantly in-
creased by exposure to copper, compared with control (**P6 0.05;
*P6 0.01 Student’s unpaired t-test). Data are presented as means
TS.E.M. of four to six separate determinations in each group. Two
representative bands from control and copper-treated cells run on
the same gel are shown above the data bars for each IREG1 and
for villin (b) and L-actin (c) in the same cell samples to show equal
loading of protein and RT-PCR products onto gels. Copper treat-
ment did not a¡ect villin or L-actin densities compared with control
cells.
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line but, unlike DMT1, mRNA levels were not in£uenced by
incubation with copper-loaded medium (Fig. 3). These ¢nd-
ings are consistent with previous studies with rats, which de-
spite being fed a high copper diet showed no regulation of
Ctr1 expression in either the liver or the intestine [7]. How-
ever, Ctr1 does function as a copper transporter and is ex-
pressed at the plasma membrane of a transfected human cell
line [10]. It is possible that transport function and protein
expression could be regulated by copper at the post-transla-
tional level, similar to the situation that occurs in yeast [4].
Clearly, despite the evidence that Ctr1 can function as a trans-
porter, further studies are necessary to determine the role of
Ctr1 in intestinal copper homeostasis.
Previous studies have shown that copper de¢ciency results
in tissue retention of iron [27,28] and in many cases leads to a
microcytic hypochromic anaemia similar to that seen in iron
de¢ciency [28], which can be normalised by administration of
copper but not iron [29]. Hence, there seems to be a reciprocal
arrangement between cellular copper and iron status. To test
the hypothesis that high copper levels should increase iron
e¥ux from Caco-2 TC7 cells, we measured accumulation of
55Fe in the basolateral medium. Following exposure to cop-
per, iron e¥ux (when normalised to the level of uptake across
the apical membrane) increased by approximately 40% (Fig.
4a). A key component in the cellular release of iron is the
basolateral iron transporter IREG1 [30] ^ also known as fer-
roportin 1 and MTP1 [31,32]. Intriguingly, and in agreement
with our e¥ux data, exposure to high levels of copper in-
creased both IREG1 protein and mRNA expression in
Caco-2 TC7 cells (Fig. 4b,c). Previous studies have shown
that IREG1 mRNA is increased in response to changes in
body iron status [30,31] and following exposure to high levels
of zinc [19]. The mechanisms involved in the regulation of
IREG1 by metal ion status are unclear but may be related
to regulatory elements in the IREG1 promoter.
In summary, two possible copper transporters DMT1 and
Ctr1 are expressed in the Caco-2 TC7 cell model of human
intestinal epithelial cells (Fig. 5). The relative contribution of
these proteins to intestinal copper homeostasis at this time is
unclear. Whilst evidence points towards DMT1 acting as a
transporter of divalent metals [12,13], Ctr1 appears to trans-
port monovalent ions including Cu (I) and Ag (I) [10]. Since
copper is largely present as Cu (II) in the diet, it would ¢rst
have to be reduced to Cu (I) to be transported via Ctr1. There
are numerous mechanisms potentially capable of reducing
copper including endogenous plasma membrane reductases
[33,34] as well as dietary components such as ascorbate. How-
ever, previous work has suggested that reduction of dietary
copper into its cuprous state (for example, by ascorbate) in-
hibits absorption [35]. Clearly there are several issues relating
to copper bioavailability that remain to be resolved. Current
work in our laboratory is attempting to delineate between
these two potential copper transporting mechanisms and
should determine the relative role of each in maintaining in-
testinal copper homeostasis.
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